Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Tyche Industries Ltd. is currently lagging behind its peers in almost every key metric, showing no growth and profitability. In contrast, companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. demonstrate strong profitability and growth, making them sector leaders. Sun Pharmaceutical Industries Ltd. appears overvalued, while Tyche Industries Ltd.'s low valuation may suggest it as a potential deep value pick if growth resumes.
Highest ROE (16.63%) and consistent revenue growth (YoY 13.28%) with a reasonable PE ratio.
Strong profitability metrics (ROE 21.76%, EBITDA Margin 27.09%) and growth (YoY 16.54%).